‘We will end up potentially having problems with immune response’
“And I know that Israel already started some of these experiments, and we will also conduct some of these experiments to make sure that if needed, we’ll use it. I don’t think we should do anything that is not needed.”
So said Albert Bourla, CEO of Pfizer, on January 10, 2022, with regard to a fourth dose of his company’s COVID vaccine. Israel, of course, isn’t referring to its second booster shot program as an “experiment” – Prime Minister Naftali Bennett proudly announced the availability of a fourth dose to those over the age of sixty and the immunocompromised, telling the country: “The State of Israel will continue to stand at the forefront of the global response to the pandemic. Israeli citizens were the first in the world to receive a third vaccine dose, and we are continuing to lead with the fourth round of vaccinations.”
Not a single study had been made at the time of this speech to assess either the efficacy or the safety of a fourth dose – unsurprisingly, as Bourla never (at least publicly) anticipated a need for a second booster shot. Originally, the Pfizer vaccine was supposed to be a two-dose regimen that would “end the pandemic.”
So, there are now hundreds of thousands of Israeli guinea pigs thinking themselves lucky. Interestingly, former Prime Minister Binyamin Netanyahu is not one of them, even though he is over the age of sixty. Considering that he probably has better access than most to the real facts about the “vaccines” he was instrumental in bringing to the country he then led, it would be fascinating to know why he’s made the decision to hold off on that second booster shot.
Has Bourla himself received a second booster? Back in December, he was still sounding pretty enthusiastic about boosters in general. That’s just a few weeks ago, but these days, politicians and pharma executives can count on most of us having short memories.
In an interview with CNBC on December 8, 2021, Bourla was asked: “Just to clarify things: All three of the shots – the two original shots and then the booster shot – it’s the same formulation. It’s the same thing. Is it a combination of those three working together and somehow making it work better against the Omicron variant or is this just a situation where people who got the shot a while ago and then are boosted and updated, that’s what provides the effectiveness?”